Update on Levetiracetam in Infants and Children

Marcia L. Buck, PharmD, FCCP, FPPAG, BCPPS


Pediatr Pharm. 2018;24(7) 

In This Article


Levetiracetam has become a common choice for the prevention or treatment of seizures for infants and children in a variety of clinical settings. It offers several advantages over traditional antiepileptics, most notably a relatively mild adverse effect profile and a lack of significant drug interactions. Within the past two years, a number of papers have been published supporting its use and defining its safety profile. These papers add to our understanding of the drug, while serving as a reminder of the need for continued study to optimize its use and identify rare adverse effects.